104 related articles for article (PubMed ID: 19015174)
21. Tumour angiogenesis: its mechanism and therapeutic implications in malignant gliomas.
Wong ML; Prawira A; Kaye AH; Hovens CM
J Clin Neurosci; 2009 Sep; 16(9):1119-30. PubMed ID: 19556134
[TBL] [Abstract][Full Text] [Related]
22. Quantitative analysis of dynamic contrast enhanced MRI for assessment of bowel inflammation in Crohn's disease pilot study.
Oto A; Fan X; Mustafi D; Jansen SA; Karczmar GS; Rubin DT; Kayhan A
Acad Radiol; 2009 Oct; 16(10):1223-30. PubMed ID: 19524458
[TBL] [Abstract][Full Text] [Related]
23. Usefulness of diffusion-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging in the diagnosis of prostate transition-zone cancer.
Yoshizako T; Wada A; Hayashi T; Uchida K; Sumura M; Uchida N; Kitagaki H; Igawa M
Acta Radiol; 2008 Dec; 49(10):1207-13. PubMed ID: 19031184
[TBL] [Abstract][Full Text] [Related]
24. Acute hyperenhancement on delayed contrast-enhanced magnetic resonance imaging is the characteristic sign after coronary microembolization.
Ma JY; Qian JY; Jin H; Chen ZW; Chang SF; Yang S; Sun AJ; Zeng MS; Zou YZ; Ge JB
Chin Med J (Engl); 2009 Mar; 122(6):687-91. PubMed ID: 19323935
[TBL] [Abstract][Full Text] [Related]
25. A multiphase model describing vascular tumour growth.
Breward CJ; Byrne HM; Lewis CE
Bull Math Biol; 2003 Jul; 65(4):609-40. PubMed ID: 12875336
[TBL] [Abstract][Full Text] [Related]
26. Transcriptional switch of dormant tumors to fast-growing angiogenic phenotype.
Almog N; Ma L; Raychowdhury R; Schwager C; Erber R; Short S; Hlatky L; Vajkoczy P; Huber PE; Folkman J; Abdollahi A
Cancer Res; 2009 Feb; 69(3):836-44. PubMed ID: 19176381
[TBL] [Abstract][Full Text] [Related]
27. Phase I dose escalation study of telatinib, a tyrosine kinase inhibitor of vascular endothelial growth factor receptor 2 and 3, platelet-derived growth factor receptor beta, and c-Kit, in patients with advanced or metastatic solid tumors.
Eskens FA; Steeghs N; Verweij J; Bloem JL; Christensen O; van Doorn L; Ouwerkerk J; de Jonge MJ; Nortier JW; Kraetzschmar J; Rajagopalan P; Gelderblom H
J Clin Oncol; 2009 Sep; 27(25):4169-76. PubMed ID: 19636022
[TBL] [Abstract][Full Text] [Related]
28. Where are we with imaging oxygenation in human tumours?
Padhani AR
Cancer Imaging; 2005 Nov; 5(1):128-30. PubMed ID: 16321774
[TBL] [Abstract][Full Text] [Related]
29. mTOR inhibitor RAD001 (everolimus) has antiangiogenic/vascular properties distinct from a VEGFR tyrosine kinase inhibitor.
Lane HA; Wood JM; McSheehy PM; Allegrini PR; Boulay A; Brueggen J; Littlewood-Evans A; Maira SM; Martiny-Baron G; Schnell CR; Sini P; O'Reilly T
Clin Cancer Res; 2009 Mar; 15(5):1612-22. PubMed ID: 19223496
[TBL] [Abstract][Full Text] [Related]
30. Treatment of rodent liver tumor with combretastatin a4 phosphate: noninvasive therapeutic evaluation using multiparametric magnetic resonance imaging in correlation with microangiography and histology.
Wang H; Sun X; Chen F; De Keyzer F; Yu J; Landuyt W; Vandecaveye V; Peeters R; Bosmans H; Hermans R; Marchal G; Ni Y
Invest Radiol; 2009 Jan; 44(1):44-53. PubMed ID: 19034028
[TBL] [Abstract][Full Text] [Related]
31. Expression of angiogenesis-related genes regulates different steps in the process of tumor growth and metastasis in human urothelial cell carcinoma of the urinary bladder.
Chikazawa M; Inoue K; Fukata S; Karashima T; Shuin T
Pathobiology; 2008; 75(6):335-45. PubMed ID: 19096229
[TBL] [Abstract][Full Text] [Related]
32. Angiogenesis is continuous with two peaks during azaserine-induced rat pancreatic adenocarcinoma progression: an electron microscopic morphometrical study.
Nagy K; Tóth S; Pálfia Z; Réz G
Oncol Rep; 2003; 10(6):1999-2004. PubMed ID: 14534733
[TBL] [Abstract][Full Text] [Related]
33. Vascular remodelling of an arterio-venous blood vessel network during solid tumour growth.
Welter M; Bartha K; Rieger H
J Theor Biol; 2009 Aug; 259(3):405-22. PubMed ID: 19371750
[TBL] [Abstract][Full Text] [Related]
34. Quantitative molecular magnetic resonance imaging of tumor angiogenesis using cNGR-labeled paramagnetic quantum dots.
Oostendorp M; Douma K; Hackeng TM; Dirksen A; Post MJ; van Zandvoort MA; Backes WH
Cancer Res; 2008 Sep; 68(18):7676-83. PubMed ID: 18794157
[TBL] [Abstract][Full Text] [Related]
35. Noninvasive photoacoustic imaging of the developing vasculature during early tumor growth.
Lao Y; Xing D; Yang S; Xiang L
Phys Med Biol; 2008 Aug; 53(15):4203-12. PubMed ID: 18635896
[TBL] [Abstract][Full Text] [Related]
36. A simple mechanistic model of sprout spacing in tumour-associated angiogenesis.
Addison-Smith B; McElwain DL; Maini PK
J Theor Biol; 2008 Jan; 250(1):1-15. PubMed ID: 18028960
[TBL] [Abstract][Full Text] [Related]
37. Fundamentals of quantitative dynamic contrast-enhanced MR imaging.
Paldino MJ; Barboriak DP
Magn Reson Imaging Clin N Am; 2009 May; 17(2):277-89. PubMed ID: 19406359
[TBL] [Abstract][Full Text] [Related]
38. Prostate cancer detection with multi-parametric MRI: logistic regression analysis of quantitative T2, diffusion-weighted imaging, and dynamic contrast-enhanced MRI.
Langer DL; van der Kwast TH; Evans AJ; Trachtenberg J; Wilson BC; Haider MA
J Magn Reson Imaging; 2009 Aug; 30(2):327-34. PubMed ID: 19629981
[TBL] [Abstract][Full Text] [Related]
39. Tracer kinetics analysis of dynamic contrast-enhanced CT and MR data in patients with squamous cell carcinoma of the upper aerodigestive tract: comparison of the results.
Bisdas S; Baghi M; Wagenblast J; Bisdas T; Thng CH; Mack MG; Koh TS; Ernemann U
Clin Physiol Funct Imaging; 2009 Sep; 29(5):339-46. PubMed ID: 19473200
[TBL] [Abstract][Full Text] [Related]
40. Benign prostatic hyperplasia: evaluation of T1, T2, and microvascular characteristics with T1-weighted dynamic contrast-enhanced MRI.
Kershaw LE; Hutchinson CE; Buckley DL
J Magn Reson Imaging; 2009 Mar; 29(3):641-8. PubMed ID: 19243046
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
